Fig. 7.

Changes in alkenyl chain composition of alkenyl phosphatidylethanolamine species after shark liver oil supplementation. Bars represent the mean relative abundance (whiskers represent ± standard error of mean) of (A) P-16:0, P-18:0, and P-18:1 and (B) P-20:0 and P-20:1 alkenyl chains in the alkenyl phosphatidylethanolamine [PE(P)] species before and after placebo or SLO treatment (before placebo: pale blue bar; after placebo: dark blue bar; before treatment: pale red bar and after treatment: dark red bar), irrespective of the intervention order. The nominal significance of the treatment effect was determined using repeated measures ANOVA; ∗∗∗ indicates P < 0.001. PE(P), alkenyl phosphatidylethanolamine; SLO, shark liver oil.